ATPC (Agape ATP) Short-Term Debt to Capital

Corporate company logo of Agape ATP Corp (ATPC)

Agape ATP Corporation (ATPC) enjoys high consumer trust within the Asian wellness programs segment. The market capitalization trend on the GURU.Markets platform, which currently stands at 0.00, reflects the dynamics of a company striving for dominance in metabolic pharma through digital wellness services. Business growth is driven by the development of personalized medicine and the demand for dietary supplements in Southeast Asia.

Ratio of Short-Term Indebtedness to Capital: agapeatpgroup.com (ATPC) for 02/21/2024 - 11/01/2026

Analytical breakdowns for Agape ATP Corporation

- stock quotes and analyst forecast:
Stock Price Agape ATP Corporation|ATPC - Fair Value Consensus
- business market valuation indicators:
Market Capitalization Agape ATP Corp|ATPC - Enterprise Value
- book capitalization information:
Net Assets per Single Share Agape ATP|ATPC - Accounting Value of Company|Market Value to Book Value Ratio agapeatpgroup.com|ATPC - Cumulative Company Assets
- company liabilities and liquidity data:
Total Debt to Capital Agape ATP Corporation|ATPC - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Agape ATP Corporation|ATPC - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Agape ATP Corp|ATPC - Company Long-Term Liabilities|Company Short-Term Debts Agape ATP|Quick Liquidity Indicator agapeatpgroup.com
- company profitability and valuation multiples indicators:
ATPC - Profit After Payment of Taxes
Fundamental valuation:ATPC Agape ATP
Brand item of agapeatpgroup.com

This ratio is calculated as the proportion of liabilities maturing within one year to equity, determining the operational dependence on short-term borrowing. For Agape ATP Corporation (ATPC), which leverages high loyalty among Asian dietary supplement consumers, the current short-term debt-to-equity level reflects a balance between financial stability and the pace of the brand's expansion within the longevity market.

Competitors of Agape ATP Corporation

Short-Term Debt to Capital ASND|MDGL (Madrigal Corp) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital CORT (Corcept Therapeutics)|Short-Term Debt to Capital rhythmtx.com RYTM|AKRO - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital MTSR (Metsera, Inc.)|MoonLake Pharma (MLTX) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Crinetics Corp|NAMS (NewAmsterdam Pharma) - Short-Term Debt to Capital|Short-Term Debt to Capital soleno.life|Short-Term Debt to Equity Ratio FOLD (Amicus Therapeutics, Inc.)|ETNB (89bio Inc) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Agios Pharmaceuticals Inc AGIO|GPCR - Short-Term Debt to Equity Ratio|MiMedx Group, Inc. - Short-Term Debt to Capital|Current Liabilities to Capital rezolutebio.com|LXRX (Lexicon Pharmaceuticals, Inc.) - Short-Term Debt to Equity Ratio|MBX: Short-Term Loans to Capital Ratio|ALT (Altimmune Corp) - Short-Term Debt to Capital|Short-Term Debt to Capital Aardvark Pharma|Short-Term Debt to Capital SGMT|Short-Term Debt to Equity BIOA (bioagelabs.com)|Short-Term Debt to Equity Biomea Fusion BMEA|Quince Therapeutics Inc (QNCX) - Current Liabilities to Capital|GUTS - Short-Term Debt to Equity|VTVT: Short-Term Debt to Equity|PLUR: Short-Term Debt to Capital|SYBX - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Lipocine|Matinas BioPharma Holdings Inc. (MTNB) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Spruce Biosciences (SPRB)|Short-Term Debt to Equity Ratio Galecto Corporation GLTO|Short-Term Debt to Capital CTCX (Carmell Corporation)|Short-Term Debt to Capital lumos-pharma.com LUMO|Organovo - Short-Term Debt to Capital|Short-Term Indebtedness to Equity Radius Recycling Inc. (RDUS)